ARTICLE | Company News
CHMP reconfirms Qsiva negative opinion
February 22, 2013 2:05 AM UTC
Vivus Inc. (NASDAQ:VVUS) said EMA's CHMP confirmed an October opinion recommending against approval of an MAA for Vivus' obesity drug Qsiva phentermine/topiramate after the company requested a reexami...